Would you consider a 47.6% outcome for a study on mood disorders significant? What would you say if this published study was on a micronutrient supplement and not a drug?
Last week, a ground-breaking study published in the British Medical Journal cited that researchers at the University of Canterbury in NZ found the micronutrient supplement Truehope EMPowerplus had significant benefits for adults with psychiatric symptoms of ADHD, depression, hyperactivity, impulsivity and inattention. The research publication also identified a major reduction in symptoms in those suffering from ‘moderate’ to ‘severe’ depression.
Truehope founder, Anthony Stephan believes that this research places EMPowerplus in a new class of first line treatments for the most common mood disorders. The safety profile of the product has been researched extensively and has been proven safe in use over the past 16 years. EMPowerplus has now been the subject of 24 clinical studies.
Recently, Anthony appeared on the Holy Hormones Honey! radio show to discuss the new study and the implications it has for Truehope, as well as the mental health care industry in general.
Listen to the interview now!
Let us know your thoughts in the comments below.